Joseph Group Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Buy |
7,760
+634
| +9% | +$282K | 1.16% | 34 |
|
|
2025
Q1 | $3.45M | Buy |
7,126
+704
| +11% | +$341K | 1.32% | 26 |
|
|
2024
Q4 | $2.59M | Buy |
6,422
+750
| +13% | +$302K | 1.02% | 35 |
|
|
2024
Q3 | $2.64M | Buy |
5,672
+855
| +18% | +$398K | 1.01% | 29 |
|
|
2024
Q2 | $2.26M | Buy |
4,817
+426
| +10% | +$200K | 1.17% | 25 |
|
|
2024
Q1 | $1.84M | Buy |
4,391
+643
| +17% | +$269K | 0.92% | 38 |
|
|
2023
Q4 | $1.53M | Buy |
3,748
+310
| +9% | +$126K | 0.89% | 31 |
|
|
2023
Q3 | $1.2M | Buy |
+3,438
| New | +$1.2M | 0.86% | 38 |
|